Your browser doesn't support javascript.
loading
Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming.
Picard, Martin; Zhang, Jiangwen; Hancock, Saege; Derbeneva, Olga; Golhar, Ryan; Golik, Pawel; O'Hearn, Sean; Levy, Shawn; Potluri, Prasanth; Lvova, Maria; Davila, Antonio; Lin, Chun Shi; Perin, Juan Carlos; Rappaport, Eric F; Hakonarson, Hakon; Trounce, Ian A; Procaccio, Vincent; Wallace, Douglas C.
Affiliation
  • Picard M; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
  • Zhang J; School of Biological Sciences, The University of Hong Kong, Hong Kong, People's Republic of China;
  • Hancock S; Trovagene, San Diego, CA 92130;
  • Derbeneva O; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
  • Golhar R; Center for Applied Genomics, Division of Genetics, Department of Pediatrics, and.
  • Golik P; Institute of Genetics and Biotechnology, Warsaw University, 00-927, Warsaw, Poland;
  • O'Hearn S; Morton Mower Central Research Laboratory, Sinai Hospital of Baltimore, Baltimore, MD 21215;
  • Levy S; Genomics Sevices Laboratory, HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806;
  • Potluri P; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
  • Lvova M; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
  • Davila A; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
  • Lin CS; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;
  • Perin JC; Nucleic Acid/Protein Research Core Facility, Children's Hospital of Philadelphia, Philadelphia, PA 19104;
  • Rappaport EF; Nucleic Acid/Protein Research Core Facility, Children's Hospital of Philadelphia, Philadelphia, PA 19104;
  • Hakonarson H; Trovagene, San Diego, CA 92130;
  • Trounce IA; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia; and.
  • Procaccio V; Department of Biochemistry and Genetics, National Center for Neurodegenerative and Mitochondrial Diseases, Centre Hospitalier Universitaire d'Angers, 49933 Angers, France.
  • Wallace DC; Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; wallaced1@email.chop.edu.
Proc Natl Acad Sci U S A ; 111(38): E4033-42, 2014 Sep 23.
Article de En | MEDLINE | ID: mdl-25192935
ABSTRACT
Variation in the intracellular percentage of normal and mutant mitochondrial DNAs (mtDNA) (heteroplasmy) can be associated with phenotypic heterogeneity in mtDNA diseases. Individuals that inherit the common disease-causing mtDNA tRNA(Leu(UUR)) 3243A>G mutation and harbor ∼10-30% 3243G mutant mtDNAs manifest diabetes and occasionally autism; individuals with ∼50-90% mutant mtDNAs manifest encephalomyopathies; and individuals with ∼90-100% mutant mtDNAs face perinatal lethality. To determine the basis of these abrupt phenotypic changes, we generated somatic cell cybrids harboring increasing levels of the 3243G mutant and analyzed the associated cellular phenotypes and nuclear DNA (nDNA) and mtDNA transcriptional profiles by RNA sequencing. Small increases in mutant mtDNAs caused relatively modest defects in oxidative capacity but resulted in sharp transitions in cellular phenotype and gene expression. Cybrids harboring 20-30% 3243G mtDNAs had reduced mtDNA mRNA levels, rounded mitochondria, and small cell size. Cybrids with 50-90% 3243G mtDNAs manifest induction of glycolytic genes, mitochondrial elongation, increased mtDNA mRNA levels, and alterations in expression of signal transduction, epigenomic regulatory, and neurodegenerative disease-associated genes. Finally, cybrids with 100% 3243G experienced reduced mtDNA transcripts, rounded mitochondria, and concomitant changes in nuclear gene expression. Thus, striking phase changes occurred in nDNA and mtDNA gene expression in response to the modest changes of the mtDNA 3243G mutant levels. Hence, a major factor in the phenotypic variation in heteroplasmic mtDNA mutations is the limited number of states that the nucleus can acquire in response to progressive changes in mitochondrial retrograde signaling.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transcription génétique / ADN mitochondrial / ARN messager / Mutation ponctuelle / Épigenèse génétique / Mitochondries Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Proc Natl Acad Sci U S A Année: 2014 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transcription génétique / ADN mitochondrial / ARN messager / Mutation ponctuelle / Épigenèse génétique / Mitochondries Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Proc Natl Acad Sci U S A Année: 2014 Type de document: Article
...